Friendly pharmacodynamics: A simple introduction

作者: Gwen Hughes

DOI: 10.12968/NPRE.2016.14.1.34

关键词:

摘要: Pharmacodynamics refers to the effect of a drug on body; topic encompasses not only means by which receptors interact produce their response, but also quantifies medicine's effects individuals and even populations. Understanding basics pharmacodynamics provides answers questions such as ‘how does this work?’ much is needed safely treat patient?’ delves into tricky fields molecular biology biological chemistry, despite depth breadth topics it spans, understanding core principles necessary for effective therapeutic practice. This article helps provide an appreciation considerations underlying drugs used concentration choices. Initially, allow how different responses are elicited, overview response given.

参考文章(41)
Sebastiano Mercadante, Opioid combination: rationale and possible clinical applications Annals of palliative medicine. ,vol. 2, pp. 189- 196 ,(2013) , 10.3978/J.ISSN.2224-5820.2013.09.04
Ye Ling, Meiling Jing, Xiang-dong Wang, Allosteric therapies for lung cancer Cancer and Metastasis Reviews. ,vol. 34, pp. 303- 312 ,(2015) , 10.1007/S10555-015-9567-Z
Georges Vauquelin, Steven J Charlton, Long‐lasting target binding and rebinding as mechanisms to prolong in vivo drug action British Journal of Pharmacology. ,vol. 161, pp. 488- 508 ,(2010) , 10.1111/J.1476-5381.2010.00936.X
M. Maureen Dale, H. P. Rang, Rang and Dale's pharmacology : Elsevier/Churchill Livingstone,. ,(2012)
Lino Sghendo, Janet Mifsud, Understanding the molecular pharmacology of the serotonergic system: using fluoxetine as a model Journal of Pharmacy and Pharmacology. ,vol. 64, pp. 317- 325 ,(2012) , 10.1111/J.2042-7158.2011.01384.X
Marco L.A. Sivilotti, Flumazenil, naloxone and the ‘coma cocktail’ British Journal of Clinical Pharmacology. ,vol. 81, pp. 428- 436 ,(2016) , 10.1111/BCP.12731
Peter A. LeWitt, Levodopa therapy for Parkinson's disease: Pharmacokinetics and pharmacodynamics. Movement Disorders. ,vol. 30, pp. 64- 72 ,(2015) , 10.1002/MDS.26082
Patrick Y. Muller, Mark N. Milton, The determination and interpretation of the therapeutic index in drug development Nature Reviews Drug Discovery. ,vol. 11, pp. 751- 761 ,(2012) , 10.1038/NRD3801
L Cristino, Letizia Palomba, V Di Marzo, None, New horizons on the role of cannabinoid CB1 receptors in palatable food intake, obesity and related dysmetabolism. International Journal of Obesity Supplements. ,vol. 4, ,(2014) , 10.1038/IJOSUP.2014.8
W Rief, U Bingel, M Schedlowski, P Enck, Mechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials Clinical Pharmacology & Therapeutics. ,vol. 90, pp. 722- 726 ,(2011) , 10.1038/CLPT.2011.204